HUTCHMED (HCM) Competitors GBX 212 +5.00 (+2.42%) As of 04/17/2025 11:50 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock HCM vs. SOPH, ITH, GRI, INDV, SLS, ERGO, SLN, BMY, AMYT, and OGNShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), Grainger (GRI), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Bloomsbury Publishing (BMY), Amryt Pharma (AMYT), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Sophos Group plc (SOPH.L) Ithaca Energy Grainger Indivior Standard Life UK Smaller Companies Trust Ergomed Silence Therapeutics Bloomsbury Publishing Amryt Pharma Origin Enterprises Sophos Group plc (SOPH.L) (LON:SOPH) and HUTCHMED (LON:HCM) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment. Do insiders & institutionals have more ownership in SOPH or HCM? 36.5% of HUTCHMED shares are owned by institutional investors. 39.0% of HUTCHMED shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is SOPH or HCM more profitable? Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to HUTCHMED's net margin of -6.87%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat HUTCHMED's return on equity.Company Net Margins Return on Equity Return on Assets Sophos Group plc (SOPH.L)N/A N/A N/A HUTCHMED -6.87%-5.71%-5.90% Does the MarketBeat Community prefer SOPH or HCM? Sophos Group plc (SOPH.L) received 221 more outperform votes than HUTCHMED when rated by MarketBeat users. Likewise, 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote while only 78.40% of users gave HUTCHMED an outperform vote. CompanyUnderperformOutperformSophos Group plc (SOPH.L)Outperform Votes41780.19% Underperform Votes10319.81%HUTCHMEDOutperform Votes19678.40% Underperform Votes5421.60% Which has stronger earnings & valuation, SOPH or HCM? Sophos Group plc (SOPH.L) has higher earnings, but lower revenue than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/AHUTCHMED£771.01M2.99-£52.98M-£3.92-54.11 Does the media favor SOPH or HCM? In the previous week, HUTCHMED had 1 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 1 mentions for HUTCHMED and 0 mentions for Sophos Group plc (SOPH.L). HUTCHMED's average media sentiment score of 0.34 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that HUTCHMED is being referred to more favorably in the news media. Company Overall Sentiment Sophos Group plc (SOPH.L) Neutral HUTCHMED Neutral SummarySophos Group plc (SOPH.L) beats HUTCHMED on 7 of the 12 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£2.30B£2.13B£5.30B£2.48BDividend Yield4.63%2.92%5.12%4.96%P/E Ratio-54.114.3321.86129.75Price / Sales2.99476.52380.54232,042.22Price / Cash2.4910.2538.2628.07Price / Book2.426.066.454.43Net Income-£52.98M£20.70B£3.22B£5.83B7 Day Performance1.92%1.55%2.85%3.01%1 Month Performance-7.42%-2.43%-8.67%-1.06%1 Year Performance-21.77%93.76%11.46%102.51% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMEDN/AGBX 212+2.4%N/A-21.5%£2.30B£771.01M-54.111,760Gap UpSOPHSophos Group plc (SOPH.L)N/AN/AN/AN/A£2.99B£726.90M341.41520ITHIthaca EnergyN/AGBX 140-0.4%N/A+18.4%£2.92B£3.55B15.99220Positive NewsHigh Trading VolumeGRIGrainger2.9263 of 5 starsGBX 211+3.2%GBX 317.50+50.5%-15.6%£1.56B£276.05M-1,406.67372Dividend IncreaseINDVIndivior1.9874 of 5 starsGBX 685.50-1.4%GBX 1,650+140.7%-55.6%£1.07B£1.40B-568.381,000Gap UpSLSStandard Life UK Smaller Companies TrustN/AN/AN/AN/A£715.41M£222.48M3.3710ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeBMYBloomsbury Publishing2.3164 of 5 starsGBX 579-0.7%GBX 825+42.5%+5.1%£467.21M£382.40M12.3934,300AMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownOGNOrigin EnterprisesN/AGBX 3.10+3.3%N/A-6.7%£327.32M£183.08B8.9610,000Dividend IncreaseGap Up Related Companies and Tools Related Companies SOPH Competitors ITH Competitors GRI Competitors INDV Competitors SLS Competitors ERGO Competitors SLN Competitors BMY Competitors AMYT Competitors OGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HCM) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.